Skip to main content
SS

Switchback Systems

Switchback Systems has developed a scalable benchtop DNA synthesis platform that integrates oligonucleotide synthesis and gene assembly capabilities, significantly reducing the time, cost, and waste associated with traditional DNA synthesis methods. This technology empowers scientists across various industries, including pharmaceuticals and agriculture, to efficiently produce custom DNA sequences for research and development.

San Francisco, United StatesFounded 202010300+ followers
Updated 4 months ago

Funding

$18.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Traditional DNA synthesis methods are often slow, expensive, and generate significant waste, creating bottlenecks in research and development across various industries. The reliance on centralized service providers for custom DNA sequences can also lead to delays and concerns about confidentiality.

Solution

Switchback Systems offers a benchtop DNA synthesis platform that integrates oligonucleotide synthesis and gene assembly, enabling scientists to produce custom DNA sequences in-house. The system is designed to minimize time, cost, and waste associated with traditional DNA synthesis approaches. By placing DNA synthesis capabilities directly in the hands of scientists, Switchback Systems aims to accelerate research and development in pharmaceuticals, agriculture, and other fields. The platform's streamlined, self-contained design eliminates the need for outsourcing DNA synthesis, providing faster turnaround times and guaranteed confidentiality.

Target Audience

The primary target audience includes scientists and researchers in pharmaceuticals, agriculture, diagnostics, gene therapy, cancer treatments, aquaculture, and other industries requiring custom DNA sequences.

Features

  • Integrated oligonucleotide synthesis and gene assembly capabilities on a single benchtop platform
  • Simplified, plug-and-play design for ease of use and rapid deployment
  • Minimized waste generation compared to traditional DNA synthesis methods
  • Faster turnaround times for custom DNA sequences
  • Enhanced sequence fidelity for accurate results
  • Guaranteed confidentiality of synthesized sequences
This profile is AI-generated and may contain inaccuracies.